Menüü

Otsi

SARS-CoV-2 S1 UK B1.1.7 nat

SARS-CoV-2 S1 UK B1.1.7 nat  

Figure 1. Coomassie-stained SDS-PAGE analysis of SARS-CoV-2 S1 UK B1.1.7 nat. 4-12% gradient gel is used for analysis. Lane 1. 0.8 µg SARS-CoV-2 S1 UK B1.1.7 nat (-DTT). Lane 2. Protein marker (Smobio). Lane 3. 0.8 µg SARS-CoV-2 S1 UK B1.1.7 nat (+DTT).

      SARS-CoV-2 S1 UK B1.1.7 nat  

Figure 2. HPLC analytical SEC for final product.

      SARS-CoV-2 S1 UK B1.1.7 nat  

Figure 3. HPLC analytical SEC after 3 freeze-thaw cycles.

      SARS-CoV-2 S1 UK B1.1.7 nat  

Figure 4. Octet RED96e analysis of SARS-CoV-2 S1 UK B1.1.7 nat binding to the ACE2 receptor.

Select volume:

Quantity:

€ 1650

Catalogue #

P-356-100

Name

SARS-CoV-2 S1 UK B1.1.7 nat

Description

Protein contains amino acids 14-681, mutations HV 69-70 del, Y144 del, N501Y, A570D, D614G, P681H.

Uniprot ID

P0DTC2

MW

74.92 kDa

Host

CHO-based cell line (expressed by QMCF Technology)

Purification

Metal-affinity chromatography following gel filtration. Protein is sterile-filtrated through 0.22 µm filter.

Concentration

1 mg/ml

Buffer

PBS pH 7.4

Endotoxine

NA

Bioproperties

Measured by its binding ability to ACE2 protein by OCTET RED96 system.

QC

SDS-PAGE, NanoDrop A280, Analytical SEC, Octet binding to ACE2

Shipping

Shipped on dry ice.

Storage

Store at -70°C upon receipt. Recommended to aliquot into smaller quantities. Avoid repeated freeze-thaw cycles

This product is for research use only

TECHNICAL ASSISTANCE

Please refer any technical questions to

technical.support@icosagen.com

Meie asukoht

Ameerika Ühendriikide kontor

77 Geary St. 5th Floor
San Francisco, CA 94108
+1 415 548 6625

Eesti kontor

Eerika tee 1
Õssu, Kambja vald
Tartu maakond 61713
Estonia
+372 737 7070
Shopping Cart